📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Renova Therapeutics

1.1 - Company Overview

Renova Therapeutics Logo

Renova Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of gene therapies for chronic diseases, focusing on cardiovascular and metabolic indications. Offerings include RT-100, a single-dose therapy to improve heart function in congestive heart failure; RT-200, a single intravenous therapy to normalize blood glucose in Type 2 Diabetes Mellitus; and paracrine gene therapy enabling systemic delivery of therapeutic genes.

Products and services

  • Paracrine Gene Therapy: A novel approach focusing on systemic delivery of therapeutic genes to improve function in chronic cardiovascular and metabolic diseases (systemic)
  • RT-100 for Congestive Heart Failure: RT-100 is a gene therapy engineered to improve heart function in patients with congestive heart failure through a single-dose treatment
  • RT-200 for Type 2 Diabetes Mellitus: RT-200 is a gene therapy developed to normalize blood glucose levels in patients with Type 2 Diabetes Mellitus through a single intravenous dose

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Renova Therapeutics

Arbor Biotechnologies Logo

Arbor Biotechnologies

HQ: United States Website
  • Description: Provider of next-generation gene editing therapeutics and tools to create targeted genetic medicines for liver and CNS diseases, supported by an AI/ML-powered discovery engine for high-throughput screening. Develops lipid nanoparticle-delivered liver therapies, AAV-delivered CNS therapies, and partners on ex vivo cell-based therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arbor Biotechnologies company profile →
Synlogic Logo

Synlogic

HQ: United States Website
  • Description: Provider of synthetic biotic medicines designed to perform metabolic functions to treat diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Synlogic company profile →
CGC Genetics Logo

CGC Genetics

HQ: Portugal Website
  • Description: Provider of medical genetics services with great technological capacity in clinical genomics, molecular diagnostics, cytogenetics, prenatal screening, and pathology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CGC Genetics company profile →
EpiBiome Logo

EpiBiome

HQ: United States Website
  • Description: Provider of precision microbiome engineering focused on developing alternatives to small-molecule antibiotics for use in healthcare, veterinary, and agriculture industries to address antibiotic resistance.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EpiBiome company profile →
Yourgene Health Logo

Yourgene Health

HQ: United Kingdom Website
  • Description: Provider of molecular diagnostics employing next generation DNA analysis technology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Yourgene Health company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Renova Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Renova Therapeutics

2.2 - Growth funds investing in similar companies to Renova Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Renova Therapeutics

4.2 - Public trading comparable groups for Renova Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Renova Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Renova Therapeutics

What does Renova Therapeutics do?

Renova Therapeutics is a provider of gene therapies for chronic diseases, focusing on cardiovascular and metabolic indications. Offerings include RT-100, a single-dose therapy to improve heart function in congestive heart failure; RT-200, a single intravenous therapy to normalize blood glucose in Type 2 Diabetes Mellitus; and paracrine gene therapy enabling systemic delivery of therapeutic genes.

Who are Renova Therapeutics's competitors?

Renova Therapeutics's competitors and similar companies include Arbor Biotechnologies, Synlogic, CGC Genetics, EpiBiome, and Yourgene Health.

Where is Renova Therapeutics headquartered?

Renova Therapeutics is headquartered in United States.

How many employees does Renova Therapeutics have?

Renova Therapeutics has 1,000 employees 🔒.

When was Renova Therapeutics founded?

Renova Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Renova Therapeutics in?

Renova Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Renova Therapeutics

Who are the top strategic acquirers in Renova Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Renova Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Renova Therapeutics?

Top strategic M&A buyers groups and sectors for Renova Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Renova Therapeutics's sector and industry vertical

Which are the top PE firms investing in Renova Therapeutics's sector and industry vertical?

Top PE firms investing in Renova Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Renova Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Renova Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Renova Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Renova Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Renova Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Renova Therapeutics?

The key public trading comparables and valuation benchmarks for Renova Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Renova Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Renova Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Renova Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Renova Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Renova Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Renova Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Renova Therapeutics